Provided by Tiger Fintech (Singapore) Pte. Ltd.

RxSIGHT, INC.

15.04
+0.12000.80%
Post-market: 15.040.00000.00%17:17 EDT
Volume:626.45K
Turnover:9.45M
Market Cap:611.18M
PE:-22.54
High:15.30
Open:15.02
Low:14.72
Close:14.92
Loading ...

BUZZ-Jefferies starts coverage on Rxsight with 'buy' on growth potential

Reuters
·
24 Mar

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Beacon Roofing, Liberty Energy

Reuters
·
24 Mar

Rxsight Inc : Jefferies Initiates Coverage With Buy Rating; Price Target $50

THOMSON REUTERS
·
24 Mar

RxSight Is Maintained at Buy by B of A Securities

Dow Jones
·
21 Mar

RxSight (RXST) Gets a Hold from Stifel Nicolaus

TIPRANKS
·
19 Mar

Promising Growth and Competitive Edge: A Buy Rating for RxSight

TIPRANKS
·
04 Mar

Top Premarket Gainers

MT Newswires Live
·
04 Mar

RxSight, Inc. Reports Strong Revenue Growth Amid Challenges

TIPRANKS
·
28 Feb

RxSight Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
27 Feb

Stock Track | RxSIGHT, INC. (RXST) Plunges 6.06% as Analysts Lower Price Targets

Stock Track
·
26 Feb

Stifel Nicolaus Sticks to Their Hold Rating for RxSight (RXST)

TIPRANKS
·
26 Feb

RxSight price target lowered to $44 from $58 at BTIG

TIPRANKS
·
26 Feb

RxSight Price Target Maintained With a $43.00/Share by Needham

Dow Jones
·
26 Feb

Rxsight, Inc. : Wells Fargo Cuts Target Price to $35 From $40

THOMSON REUTERS
·
26 Feb

RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

GuruFocus.com
·
26 Feb

Rxsight Inc : Btig Cuts Target Price to $44 From $58

THOMSON REUTERS
·
26 Feb

RxSight, Inc. Reports Strong 2024 Financial Growth

TIPRANKS
·
26 Feb

Rxsight Inc : JP Morgan Cuts Target Price to $40 From $62

THOMSON REUTERS
·
26 Feb

BTIG Keeps Their Buy Rating on RxSight (RXST)

TIPRANKS
·
26 Feb

RxSight, Inc. (RXST) Misses Q4 Earnings Estimates

Zacks
·
26 Feb